AcelRx Pharmaceuticals (ACRX) Insider Trading & Ownership → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ACRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability AcelRx Pharmaceuticals (NASDAQ:ACRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$15,300.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$11,131.38 Get ACRX Insider Trade Alerts Want to know when executives and insiders are buying or selling AcelRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACRX Insider Buying and Selling by Quarter Ad GoldenCrest MetalsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.Learn More Now AcelRx Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2023Vincent J AngottiCEOBuy10,000$0.73$7,300.00 9/11/2023Vincent J AngottiCEOBuy10,000$0.80$8,000.00 8/24/2023Pamela P PalmerInsiderSell9,514$1.17$11,131.38 (Data available from 1/1/2013 forward) ACRX Insider Trading Activity - Frequently Asked Questions Who is on AcelRx Pharmaceuticals's Insider Roster? The list of insiders at AcelRx Pharmaceuticals includes Pamela P Palmer, and Vincent J Angotti. Learn more on insiders at ACRX. What percentage of AcelRx Pharmaceuticals stock is owned by insiders? 3.00% of AcelRx Pharmaceuticals stock is owned by insiders. Learn more on ACRX's insider holdings. Which AcelRx Pharmaceuticals insiders have been buying company stock? The following insider purchased ACRX shares in the last 24 months: Vincent J Angotti ($25,508.00). How much insider buying is happening at AcelRx Pharmaceuticals? Insiders have purchased a total of 66,400 ACRX shares in the last 24 months for a total of $25,508.00 bought. Which AcelRx Pharmaceuticals insiders have been selling company stock? The following insider sold ACRX shares in the last 24 months: Pamela P Palmer ($11,131.38). How much insider selling is happening at AcelRx Pharmaceuticals? Insiders have sold a total of 9,514 AcelRx Pharmaceuticals shares in the last 24 months for a total of $11,131.38 sold. More Insider Trading Tools from MarketBeat Related Companies: VBI Vaccines Insider Buying Cocrystal Pharma Insider Buying Edesa Biotech Insider Buying Orgenesis Insider Buying Pieris Pharmaceuticals Insider Buying Aytu BioPharma Insider Buying Avalo Therapeutics Insider Buying Monopar Therapeutics Insider Buying Tonix Pharmaceuticals Insider Buying Benitec Biopharma Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:ACRX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe Greatest Bull Market in Crypto History…Weiss RatingsNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AcelRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
